Eslicarbazepine Acetate and Moxetumomab Pasudotox-tdfk
Determining the interaction of Eslicarbazepine Acetate and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: eslicarbazepine
Brand name: Aptiom
Synonyms: Eslicarbazepine
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eslicarbazepine Acetate-Moxetumomab pasudotox-tdfk Intravenous
- Eslicarbazepine Acetate-Moxifloxacin
- Eslicarbazepine Acetate-Moxifloxacin (Systemic)
- Eslicarbazepine Acetate-Moxifloxacin Hydrochloride
- Eslicarbazepine Acetate-Moxifloxacin Injection
- Eslicarbazepine Acetate-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Esmolol
- Moxetumomab Pasudotox-tdfk-Esmolol HCl
- Moxetumomab Pasudotox-tdfk-Esmolol Hydrochloride
- Moxetumomab Pasudotox-tdfk-Esmolol Injection
- Moxetumomab Pasudotox-tdfk-Esmolol Intravenous
- Moxetumomab Pasudotox-tdfk-Esomep-EZS